Comparing rehabilitation methods after hip arthroscopy
Comparison of Methods in Post Operative Hip Arthroscopy Rehabilitation
NA · University of Colorado, Denver · NCT05165927
This study tests whether adding blood flow restriction therapy to standard rehab helps people recover better after hip surgery.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | University of Colorado, Denver (other) |
| Locations | 1 site (Englewood, Colorado) |
| Trial ID | NCT05165927 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of blood flow restriction (BFR) therapy in the rehabilitation process following hip arthroscopy. Participants will be randomly assigned to either a control group receiving standard rehabilitation or an intervention group that incorporates BFR therapy into their rehabilitation protocol. The treatment will last for 12 weeks, with follow-up assessments extending up to 2 years post-surgery. The study aims to evaluate the impact of BFR on recovery outcomes for patients with various hip injuries.
Who should consider this trial
Good fit: Ideal candidates include patients with specific hip injuries such as labral tears or femoroacetabular impingement syndrome who are undergoing hip arthroscopy.
Not a fit: Patients with contraindications to BFR therapy or those undergoing bilateral hip surgeries within a short timeframe may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance recovery and rehabilitation outcomes for patients undergoing hip arthroscopy.
How similar studies have performed: Previous studies have shown promising results with BFR therapy in rehabilitation, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with labral tears, femoroacetabular impingement syndrome, loose bodies, ligamentum teres tears, and related intra-articular pathology to be treated with hip arthroscopy. Patients must also have access to a smartphone device in order to utilize the SAGA BFR application for use. The application is free to use. Exclusion Criteria: * bilateral hip surgeries to be performed within 12 weeks of each other, concomitant Peri-acetabular osteotomy, soft tissue repairs (hamstring, glute repairs), clinically diagnosed hip dysplasia, and the following BFR contraindications: * Deep Vein Thrombosis (DVT) * Pulmonary Embolism * Hemorrhagic/Thrombolytic Stroke * Clotting Disorders * Hemophilia or taking blood thinners * Pregnant or up to 6 months post-partum * Untreated Hypertension * Untreated Hypotension * Rhabdomyolysis or recent traumatic injury
Where this trial is running
Englewood, Colorado
- UCHealth Steadman Hawkins Clinic Denver — Englewood, Colorado, United States (RECRUITING)
Study contacts
- Principal investigator: James Genuario, MD — University of Colorado SOM
- Study coordinator: Lauren M Heylmun, BS
- Email: lauren.heylmun@cuanschutz.edu
- Phone: 7205169823
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hip Injuries